Sandoz, a Novartis division, is a global leader in generic pharmaceuticals and biosimilars. Our purpose is to pioneer access for patients by developing and commercializing novel, affordable approaches that address unmet medical needs. Our ambition is to be the world’s leading and most valued generics company.

Within Sandoz, the B2B unit offers Active Pharmaceutical Ingredients, Finished Dosage Forms out-licensing and supply as well as Contract Manufacturing services to partners in the industry. Delivering unique added value with complete operational and technical support, we are dedicated to giving our customers the service that boosts their business.

Sandoz BD&L and M&A team works with prospective partners to establish collaborations that are mutually beneficial and productive. We remain actively engaged with our partners to ensure a dynamic collaboration environment and maximize the probability of success.

Already a member? Log in now to take advantage of your benefits.